Brokerages Set WELL Health Technologies Corp. (TSE:WELL) Price Target at C$8.08

WELL Health Technologies Corp. (TSE:WELL) has been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is C$8.08.

A number of brokerages recently commented on WELL. CIBC decreased their price target on shares of WELL Health Technologies from C$7.00 to C$5.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 16th. Stifel Nicolaus decreased their price target on shares of WELL Health Technologies from C$10.00 to C$9.00 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. TD Securities decreased their price target on shares of WELL Health Technologies from C$8.50 to C$7.50 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. Royal Bank of Canada decreased their price target on shares of WELL Health Technologies from C$8.50 to C$7.50 and set an “outperform” rating on the stock in a research note on Monday, March 31st. Finally, Scotiabank decreased their price target on shares of WELL Health Technologies from C$8.00 to C$7.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 16th.

WELL Health Technologies Stock Up 2.9%

WELL Health Technologies stock opened at C$4.19 on Friday. The firm has a market capitalization of C$1.05 billion, a PE ratio of 14.20, a P/E/G ratio of -1.93 and a beta of 1.20. The company’s 50-day moving average is C$4.41 and its 200-day moving average is C$5.48. WELL Health Technologies has a fifty-two week low of C$3.63 and a fifty-two week high of C$7.36. The company has a debt-to-equity ratio of 46.79, a current ratio of 1.14 and a quick ratio of 1.02.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.